NCT04609436

Brief Summary

Patients hospitalized at the clinic Cecil who need telemetry will be monitored for 48 hours with the SmartCardia system in addition to conventional monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

December 8, 2023

Status Verified

December 1, 2023

Enrollment Period

29 days

First QC Date

September 29, 2020

Last Update Submit

December 7, 2023

Conditions

Keywords

non invasive monitoring

Outcome Measures

Primary Outcomes (1)

  • Arrhythmia counting after heart surgery

    The primary outcome is to detect supra-ventricular and ventricular arrhythmias following cardiac surgery. The following data will be reported: 1. Number per minute of ventricular and/or supra-ventricular extrasystoles, 2. Number per minute of supra-ventricular and/or ventricular doublets, 3. Number per minute of supra-ventricular and/or ventricular triplets, 4. Number of episodes/24 hours of supra-ventricular and/ot of ventricular tachycardia (VT) will be measured, 5. Number of episodes of atrial fibrillation will be measured. 6. Number of pause exceeding 2 seconds will be reported.

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

Secondary Outcomes (4)

  • Duration of arrhythmias after heart surgery

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

  • Noise analysis

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

  • Incidence of noise

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

  • Percentage of episodes of noise.

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

Other Outcomes (3)

  • Skin tolerance evaluation

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

  • Skin tolerance assessment (additional measures)

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

  • Skin tolerance assessment (additional measures)

    48 hours following cardiac surgery part of 10 days of hospitalization post surgery.

Study Arms (1)

Single arm

This is a single arm trial. The patient is his own control.

Device: Cardiac monitoring with the wireless device "SmartCardia"

Interventions

Monitoring of arrhythmia with a wireless device (SmartCardia)

Single arm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients requiring cardiac monitoring after heart surgery will be included

You may qualify if:

  • Any patient who needs to be monitored for at least 48 hours can be included in the study.

You may not qualify if:

  • allergic to sticking plaster
  • refusing to participate will be excluded from the study.
  • planed MRI examination
  • open wound
  • Severe thorax deformity making recording not possible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Cecil

Lausanne, 1003, Switzerland

Location

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jean-Jacques Goy, MD

    Hirslanden Cecil

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 29, 2020

First Posted

October 30, 2020

Study Start

February 1, 2020

Primary Completion

March 1, 2020

Study Completion

February 1, 2023

Last Updated

December 8, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations